RxDoctor Payments Data

Nancy Cox, NP

Nurse Practitioner · Gary, INNPI 1417328675

Payments from drug & device makers

$3,461in general payments, 2019–2025

Across 221 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$608
  • Pfizer$480
  • Collegium Pharmaceutical, Inc.$327
  • Biohaven Pharmaceutical Holding Company Ltd.$164
  • Teva Pharmaceuticals USA, Inc.$152
  • plus $494 from 10 others

What the payments were for

  • Food & beverage$3,461100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,461 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$83,134
Medicare patients
87
Services billed
2,308

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide108$97,429
RelistorMethylnaltrexone Bromide26$68,120
PercocetOxycodone Hcl/Acetaminophen11$51,170
Nurtec OdtRimegepant Sulfate25$44,587
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen872$30,895
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen691$28,633
Xtampza ErOxycodone Myristate37$20,492
GemtesaVibegron36$17,613
Lidocaine68$16,144
Oxycodone Hcl473$12,364
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,042
MovantikNaloxegol Oxalate18$10,457
Gabapentin336$6,967
Pregabalin111$4,887
Cyclobenzaprine Hcl230$4,397

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,236$97,429108 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$608$68,12026 claims
PfizerNurtec Odt$480$44,58725 claims
Collegium Pharmaceutical, Inc.Xtampza Er$327$20,49237 claims
Sumitomo Pharma America, Inc.Gemtesa$65$17,61336 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Gary

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →